CECC: Moderna vaccination services at Taipei Main Station extended to December 29, PX Mart vouchers are still offered!

To further encourage people to be vaccinated against COVID-19, Chuang Jen-hsiang (莊人祥), the spokesperson for the Central Epidemic Command Center (CECC) 指揮中心, said that the Moderna vaccination services provided at the main hall of Taipei Main Station will be extended to December 29. Besides, a PX Mart voucher worth NT$100 will still be given to individuals after vaccination.

Read More: NIA helped a lady from the Philippines without having legal status in Taiwan to get vaccinated with peace of mind

CECC aims to increase the vaccination rate in Taiwan. (Photo / Retrieved from the Pixabay)

CECC emphasized that in addition to setting up the vaccination station, it has collaborated with hospitals affiliated to the Ministry of Health and Welfare, hospitals affiliated to the Veterans Affairs Council, R.O.C., and hospitals affiliated to the Ministry of National Defense to open additional appointment slots from Monday to Friday at night to provide Moderna vaccination service.

In addition, other brands of COVID-19 vaccines can also be chosen through the "COVID-19 vaccination registration platform" or the contract-based medical institutions of the local government health bureau. The public is appealed to complete two doses of vaccines as soon as possible to protect themselves and others.

Read More: NIA Taoyuan County Service Center promotes “Carefree Covid-19 Vaccination Program”, protecting health together with migrant workers

The public is encouraged to be fully vaccinated. (Photo / Retrieved from the Pixabay)

A reminder to the public: Moderna vaccination will be provided at the west & East corridors of the main hall of Taipei Main Station, with three sites available. Eligibility is not limited to people of Taiwanese nationality.

Eligibility to get vaccinated at the Moderna vaccination site at Taipei Main Station is opened to the following individuals:

1. Individuals aged 18 and older who wish to receive the first dose of Moderna;
2. Individuals who received their first dose of Moderna at least four weeks ago;
3. Individuals who received their first dose of AstraZeneca at least eight weeks ago.